This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Insulin Delivery Pens Market

Market Insights on Insulin Delivery Pens covering sales outlook, demand forecast & up-to-date key trends

Insulin Delivery Pens Market by Product Type, Technology, Distribution Channel and By Region- Forecast for 2022 – 2032

Insulin Delivery Pens Market Size - Outlook 2022 -2032

The global insulin delivery pens market is expected to enjoy a valuation of US$ 22.4 Bn by the end of the year 2022, and further expand at a CAGR rate of 8.0% to reach a valuation of ~US$ 48.6 Bn by the year 2032. According to a recent study by Future Market Insights, smart insulin pens by-product are leading the market with a share of about 34.6% in the year 2021, within the global market.

Market Outlook:

Data Points

Market Insights

Market Value 2022

US$ 22.4 Bn

Market Value 2032

US$ 48.6 Bn

CAGR 2022-2032

8.0%

Market Share of Top 5 Countries

57.4%

Key Market Players

Eli Lilly and Company, Becton, Dickinson & Company, West Pharmaceutical Services, Inc, Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc, Mylan N.V, Vetter Pharma-Fertigung GmbH & Co.KG, Emperra GmbH, Digital Medics Pty Ltd, Enable Injections LLC, Insulet corporation, Consort Medical Plc, Diabnext, Diamesco Co., Ltd, SCHOTT AG, SiO2 Medical Products, Integrity Bio, Inc., Wilhelm Haselmeier GmbH & Co. KG, Tandem Diabetes Care, Sanofi S.A., Companion Medical Inc., Ypsomed, Hoffman - La Roche Ltd, Novo Nordisk A/S, Medtronic Plc.

Diabetes management frequently necessitates taking insulin shots throughout the day. Insulin delivery technologies, such as insulin pens, can make it considerably easier to administer insulin shots. The usage of a vial and syringe to give insulin can be replaced with an insulin pen, making diabetes management easier for patients. Insulin pens do not eliminate the necessity for needle pricks. They simply make measuring and administering insulin easier.

Insulin pens can give between 0.5 and 80 units of insulin at a time. They can deliver insulin in half-unit, one-unit, or two-unit intervals. The maximum dose and incremental amount differ between pens. The overall number of insulin units in the cartridges varies as well. Insulin pens are a practical way to control your levels of blood sugar. The insulin pens are compact and portable, containing medicine and a syringe packed within one device, making them a perfect solution for individuals on the go.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Insulin Delivery Pens Market from 2014 to 2021 Vs Market Outlook for 2022 to 2032

The market value for insulin delivery pens was approximately 3.3% of the overall ~US$ 624.5 Bn global injectable drug delivery market in 2021.

The sale of insulin delivery pens expanded at a CAGR of 6.5% from 2014 to 2021, owing to the advent of the COVID-19 global pandemic.

Insulin pens are becoming increasingly popular, and many diabetics now use a pen to inject insulin. The pens make insulin delivery easier, more accurate, and more convenient than a vial and syringe. Not everyone with diabetes will require insulin. Those who do discover that adhering to an insulin schedule can be hard, disruptive, and depleting. Some patients prefer insulin pens to make insulin administration less obtrusive and cumbersome. The demand for the insulin pen market will boost in the future as the prevalence of diabetes is on the rise.

World Health Organization (WHO) in November 2021, stated that diabetes is a long-term condition that develops when the pancreas is unable to produce sufficient insulin or when the body fails to adequately utilize the insulin that is produced well.

Hyperglycaemia, or high blood sugar, is a typical side effect of untreated diabetes, and it can cause some serious harm to many of the body functions, particularly the neurons and blood vessels, over time. Hyperglycaemia impacted 8.5% of individuals aged 18 and up in 2014. Diabetes was the primary consequence of 1.5 million fatalities in 2019, with 48% of all diabetes-related mortalities before the age of 70.

In Addition, diabetes is a leading cause of kidney failure, blindness, heart attacks, amputation of lower limbs and stroke. Diabetes-related premature mortality increased by 5% between 2000 and 2016. Regular physical activity, a nutritious diet, maintaining normal body weight, and keeping from tobacco use are all approaches to avoiding or postponing the onset of type 2 diabetes.

Thus, owing to the aforementioned factors, the global insulin delivery pens market is expected to grow at a CAGR rate value of 8.0% during the forecast period from 2022 to 2032.

Insulin Delivery Pens Market Download Report Brochure

What are the Key Opportunities for the Insulin Delivery Pens Manufacturers?

The market is likely to provide an opportunistic perspective, owing to initiatives by governments in emerging countries that are engaging significantly in healthcare infrastructure development, which is expected to broaden access to healthcare services. This is expected to boost demand for better technologies, creating an appealing opportunity in the global insulin delivery pens market.

 Technological developments and the usage of innovative designs are chosen over traditional insulin administration techniques such as syringes and needles. Insulin pen options are using smartphone and internet technologies, this speeds up and improves the accuracy of the administration process.

Emerging market participants are working on enhanced gadgets such as smart pens and smart insulin caps that can be connected via mobile technologies. Because of the internet's significance, e-commerce has grown in popularity in recent years.

Furthermore, due to social distancing regulations, the COVID-19 epidemic has produced a scenario in which e-commerce is preferred. As a result, the online availability of diabetes management solutions provides significant market growth prospects.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Insulin Delivery Pens?

The rising cost and how the technology advances in the field can hamper the market growth in the given forecast period.

Insulin pens are frequently more expensive than a vial of insulin. If the gadget must be "primed" before injection, some insulin is squandered. Access to life-saving medication is a luxury that many people in the United States cannot afford. Soaring drug prices and insufficient health insurance coverage can result in unpayable out-of-pocket expenses, undermining the right to health, driving people into financial distress and debt, and disproportionately affecting people who are socially and economically marginalised, reinforcing existing forms of structural discrimination.

For instance, a box of five Humalog KwikPens can cost more than $600 depending on your insurance and the drugstore you visit, while the recently available authorised generic can cost more than $300. Each pen is filled with 3 mL of insulin. Admelog prices vary by the drug store, but a box of five 3-mL insulin prefilled pens costs around $150.

Furthermore, individual insulin pens stored or distributed outside of their box pose an increased risk of dispensing errors and patients using the wrong substance. Individually delivered insulin pens outside of their boxes may have contributed to medication errors such as wrong-dose and wrong-drug errors resulting in hyperglycaemia or hypoglycaemia, missing doses, allegations of potential tampering, and delivery without the directions for the usage which may lead to hindrance for the market to grow.

These factors cumulatively propose a negative effect on the developmental growth of the insulin delivery pens market.

Country-wise Insights

What Makes the U.S. a Large Market for Insulin Delivery Pens?

The U.S. dominated the North American region with a total market share of over 80% in 2021 and is expected to continue to experience promising growth throughout the forecast period.

According to Human Rights Watch 2018, about 27 million adults in the United States were diagnosed with diabetes, and roughly 8.2 million adults used one or more insulin formulations to control their blood sugar. People who require insulin may have hyperglycaemia or high blood sugar which can lead to significant and even life-threatening consequences. This marks the growth of the insulin pen market in the U.S. in the coming years.

What Makes China a Highly Lucrative Market for Insulin Delivery Pens?

China held approximately 54% share in the East Asia insulin delivery pens market in 2021 and will project to display growth at a lucrative CAGR rate of 10.1% during the forecast period.

According to the International Diabetes Federation (IDF) diabetes atlas 2018, China has the world's highest diabetes population of 109.6 million, imposing a significant healthcare burden on society. Diabetes is inadequately managed in China, with less than half of individuals diagnosed achieving the HbA1c goal threshold of 7.0% (53 mmol/mol). Insulin is indicated in both national and international diabetes care guidelines for patients with inadequate glycaemic control who are receiving oral antihyperglycemic medications.

What is the Outlook of Germany in the Insulin Delivery Pens Market?

Germany is set to exhibit a CAGR growth rate of nearly 9.3% in the European insulin delivery pens market during the forecast period.

Emperra GmbH, based in Germany launched its first Bluetooth insulin pen in August 2016, Emperra is thus the only firm that can reach individuals with diabetes of all ages through a holistic creative strategy of digital solutions with smart insulin pens. As a result, the greatest community of older Type 2 diabetics on insulin is being digitally accessed for the first time.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Insulin Delivery Pens Product is Driving Insulin Delivery Pens Market Growth?

Smart insulin pens are expected to present high growth at a CAGR of 6.3% by the end of the forecast period, with nearly one third of the market share in the global market in 2021 owing to their factors like provision of precise half-unit doses, assisting in preventing missing or skipped doses, and notifications on how to treat a high blood sugar reading, keep track of the duration and dosage of each administration and set a reminder for the next one.

What Technology of Insulin Delivery Pens is Largely in Focus Globally?

Non-smart injectors held a revenue share of nearly 84.6% in 2021 and are expected to display steady growth over the forecast period. Non-smart insulin injectors can provide several shots as it is pre-filled and allows accurate dosing this is expected to fuel revenue growth over the forecast period.

Which Distribution Channel Benefits the Most with the Sales of Insulin Delivery Pens Globally?

Hospital pharmacies held the highest market share value of over 35% during the year 2021. Increasing inpatient admissions and easy prescription based medicines at hospital pharmacies are propelling sales of the overall insulin delivery pens market.

Competitive Landscape

There are several competitors in the insulin delivery pens production sphere. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

Instances of key developmental strategies by the industry players in the insulin delivery pens market are given below:

  • In August 2019, Enable Injections, Inc. (Enable), a business developing and producing investigational wearable infusion devices for combination products, announced that it has entered into a development agreement with Genentech, a Roche Group subsidiary. Enable's enFuse will enable patient-administered subcutaneous delivery of high-volume medicines.
  • In October 2019, West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices

Similarly, the team at Future Market Insights, which are available in the full report, has tracked recent developments related to companies manufacturing insulin delivery pens.

Report Scope as per Insulin Delivery Pens Industry Analysis

Attribute

Details

Forecast Period

2014-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa

Key Market Segments Covered

Product, Technology, Distribution Channel, and Region

Key Companies Profiled

  • Eli Lilly and Company
  • Becton, Dickinson & Company
  • West Pharmaceutical Services, Inc
  • Johnson & Johnson
  • Antares Pharma
  • AbbVie Inc.
  • Pfizer Inc
  • Mylan N.V
  • Vetter Pharma-Fertigung GmbH & Co.KG
  • Emperra GmbH
  • Digital Medics Pty Ltd
  • Enable Injections LLC
  • Insulet corporation
  • Consort Medical Plc
  • Diabnext
  • Diamesco Co., Ltd
  • SCHOTT AG
  • SiO2 Medical Products
  • Integrity Bio, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Tandem Diabetes Care
  • Sanofi S.A.
  • Companion Medical Inc.
  • Ypsomed
  • Hoffman - La Roche Ltd
  • Novo Nordisk A/S
  • Medtronic Plc.
  • Norgen Biotek Corp.,
  • Omega Diagnostics Group Plc.,
  • Qiagen N.V.,
  • Quidel Corporation,
  • Thermo Fisher Scientific Inc.

Pricing

Available upon Request

Key Market Segments Covered in Insulin Delivery Pens Industry Research

By Product:

  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Smart Insulin Pens

By Technology:

  • Non-Smart Injectors
  • Smart Injectors
    • Artificial Intelligence (AI) & Machine Learning Integrated
    • Near Field Communication(NFR)
    • Cloud Computing
    • Bluetooth

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global insulin delivery pens market is estimated to be worth US$ 22.4 Bn in 2021 and is set to expand 2.2X over the next ten years.

The insulin delivery pens market is expected to reach US$ 48.6 Bn by the end of 2032, with sales revenue expected to register an 8.0% CAGR.

The growing prevalence of diabetes and innovative product development, increasing adoption of insulin pens are some of the key trends in this insulin delivery pens market.

U.S., India, China, Germany, and Japan are expected to drive demand for the insulin delivery pens market.

North America is one of the key markets for insulin delivery pens, with the U.S. accounting for about 84.8% of the North American insulin delivery pens market in the year 2021.

Demand for insulin delivery pens in Europe is expected to register a growth of 7.8% over the next ten years.

Demand for insulin delivery pens in Latin America is expected to register a growth of 7.6% over the next ten years.

China and the U.S., Germany are the key producers of insulin delivery pens.

Eli Lilly and Company, Becton, Dickinson & Company, West Pharmaceutical Services, Inc, Johnson & Johnson, Antares Pharma, AbbVie Inc., Pfizer Inc, Mylan N.V, Vetter Pharma-Fertigung GmbH & Co.KG, Emperra GmbH, Digital Medics Pty Ltd, Enable Injections LLC, Insulet corporation, Consort Medical Plc, Diabnext, Diamesco Co., Ltd, SCHOTT AG, SiO2 Medical Products, Integrity Bio, Inc., Wilhelm Haselmeier GmbH & Co. KG, Tandem Diabetes Care, Sanofi S.A., Companion Medical Inc., Ypsomed, Hoffman - La Ro

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Patient Journey

    4.3. Regulatory Scenario

    4.4. Reimbursement Landscape

    4.5. PESTEL analysis

    4.6. Porter’s analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare GDP Growth Overview

        5.1.3. Global Drug Delivery Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising prevalence of Diabetic cases.

        5.2.2. Increasing awareness and adoption of Insulin Delivery Pen.

        5.2.3. New Product Launches

        5.2.4. Advancing medical technology and developments of Insulin Delivery Pen.

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Technology

        6.1.3. By Distribution Channel

        6.1.4. By Region

    6.2. 2021 Market Scenario

7. Global Insulin Delivery Pens Market Volume (Units) Analysis 2014-2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Units) Analysis, 2014-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Insulin Delivery Pens Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Insulin Delivery Pens Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product , 2014-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product , 2022–2032

        10.3.1. Reusable Insulin Pens

        10.3.2. Disposable Insulin Pens

        10.3.3. Smart Insulin Pens

    10.4. Market Attractiveness Analysis By Product

11. Global Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032, by Technology

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022–2032

        11.3.1. Non-Smart Injectors

        11.3.2. Smart Injectors

            11.3.2.1. Artificial Intelligence (AI) & Machine Learning Integrated

            11.3.2.2. Near Field Communication(NFR)

            11.3.2.3. Cloud Computing

            11.3.2.4. Bluetooth

    11.4. Market Attractiveness Analysis By Technology

12. Global Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032, by Distribution Channel

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2014-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022–2032

        12.3.1. Hospital Pharmacies

        12.3.2. Drug Stores

        12.3.3. Retail Pharmacies

        12.3.4. Online Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2014-2021

    13.3. Current Market and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By Technology

        14.4.4. By Distribution Channel

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Technology

        14.5.4. By Distribution Channel

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

    14.9. Country Level Analysis & Forecast

        14.9.1. U.S. Insulin Delivery Pens Market Analysis

            14.9.1.1. .Introduction

            14.9.1.2. Market Analysis and Forecast by Market Taxonomy

                14.9.1.2.1. By Product

                14.9.1.2.2. By Technology

                14.9.1.2.3. By Distribution Channel

        14.9.2. Canada Insulin Delivery Pens Market Analysis

            14.9.2.1. Introduction

            14.9.2.2. Market Analysis and Forecast by Market Taxonomy

                14.9.2.2.1. By Product

                14.9.2.2.2. By Technology

                14.9.2.2.3. By Distribution Channel

15. Latin America Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        15.4.1. By Country

            15.4.1.1. Mexico

            15.4.1.2. Brazil

            15.4.1.3. Argentina

            15.4.1.4. Rest of Latin America

        15.4.2. By Product

        15.4.3. By Technology

        15.4.4. By Distribution Channel

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Technology

        15.5.4. By Distribution Channel

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

    15.9. Country Level Analysis & Forecast

        15.9.1. Mexico Insulin Delivery Pens Market Analysis

            15.9.1.1. Introduction

            15.9.1.2. Market Analysis and Forecast by Market Taxonomy

                15.9.1.2.1. By Product

                15.9.1.2.2. By Technology

                15.9.1.2.3. By Distribution Channel

        15.9.2. Brazil Insulin Delivery Pens Market Analysis

            15.9.2.1. Introduction

            15.9.2.2. Market Analysis and Forecast by Market Taxonomy

                15.9.2.2.1. By Product

                15.9.2.2.2. By Technology

                15.9.2.2.3. By Distribution Channel

        15.9.3. Argentina Insulin Delivery Pens Market Analysis

            15.9.3.1. Introduction

            15.9.3.2. Market Analysis and Forecast by Market Taxonomy

                15.9.3.2.1. By Product

                15.9.3.2.2. By Technology

                15.9.3.2.3. By Distribution Channel

16. Europe Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Russia

            16.4.1.8. Rest of Europe

        16.4.2. By Product

        16.4.3. By Technology

        16.4.4. By Distribution Channel

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Technology

        16.5.4. By Distribution Channel

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

    16.9. Country Level Analysis & Forecast

        16.9.1. Germany Insulin Delivery Pens Market Analysis

            16.9.1.1. Introduction

            16.9.1.2. Market Analysis and Forecast by Market Taxonomy

                16.9.1.2.1. By Product

                16.9.1.2.2. By Technology

                16.9.1.2.3. By Distribution Channel

        16.9.2. Italy Insulin Delivery Pens Market Analysis

            16.9.2.1. Introduction

            16.9.2.2. Market Analysis and Forecast by Market Taxonomy

                16.9.2.2.1. By Product

                16.9.2.2.2. By Technology

                16.9.2.2.3. By Distribution Channel

        16.9.3. France Insulin Delivery Pens Market Analysis

            16.9.3.1. Introduction

            16.9.3.2. Market Analysis and Forecast by Market Taxonomy

                16.9.3.2.1. By Product

                16.9.3.2.2. By Technology

                16.9.3.2.3. By Distribution Channel

        16.9.4. U.K. Insulin Delivery Pens Market Analysis

            16.9.4.1. Introduction

            16.9.4.2. Market Analysis and Forecast by Market Taxonomy

                16.9.4.2.1. By Product

                16.9.4.2.2. By Technology

                16.9.4.2.3. By Distribution Channel

        16.9.5. Spain Insulin Delivery Pens Market Analysis

            16.9.5.1. Introduction

            16.9.5.2. Market Analysis and Forecast by Market Taxonomy

                16.9.5.2.1. By Product

                16.9.5.2.2. By Technology

                16.9.5.2.3. By Distribution Channel

        16.9.6. BENELUX Insulin Delivery Pens Market Analysis

            16.9.6.1. Introduction

            16.9.6.2. Market Analysis and Forecast by Market Taxonomy

                16.9.6.2.1. By Product

                16.9.6.2.2. By Technology

                16.9.6.2.3. By Distribution Channel

        16.9.7. Russia Insulin Delivery Pens Market Analysis

            16.9.7.1. Introduction

            16.9.7.2. Market Analysis and Forecast by Market Taxonomy

                16.9.7.2.1. By Product

                16.9.7.2.2. By Technology

                16.9.7.2.3. By Distribution Channel

17. South Asia Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Indonesia

            17.4.1.3. Malaysia

            17.4.1.4. Thailand

            17.4.1.5. Rest of South Asia

        17.4.2. By Product

        17.4.3. By Technology

        17.4.4. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Technology

        17.5.4. By Distribution Channel

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

    17.9. Country Level Analysis & Forecast

        17.9.1. India Insulin Delivery Pens Market Analysis

            17.9.1.1. Introduction

            17.9.1.2. Market Analysis and Forecast by Market Taxonomy

                17.9.1.2.1. By Product

                17.9.1.2.2. By Technology

                17.9.1.2.3. By Distribution Channel

        17.9.2. Indonesia Insulin Delivery Pens Market Analysis

            17.9.2.1. Introduction

            17.9.2.2. Market Analysis and Forecast by Market Taxonomy

                17.9.2.2.1. By Product

                17.9.2.2.2. By Technology

                17.9.2.2.3. By Distribution Channel

        17.9.3. Malaysia Insulin Delivery Pens Market Analysis

            17.9.3.1. Introduction

            17.9.3.2. Market Analysis and Forecast by Market Taxonomy

                17.9.3.2.1. By Product

                17.9.3.2.2. By Technology

                17.9.3.2.3. By Distribution Channel

        17.9.4. Thailand Insulin Delivery Pens Market Analysis

            17.9.4.1. Introduction

            17.9.4.2. Market Analysis and Forecast by Market Taxonomy

                17.9.4.2.1. By Product

                17.9.4.2.2. By Technology

                17.9.4.2.3. By Distribution Channel

18. East Asia Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Product

        18.4.3. By Technology

        18.4.4. By Distribution Channel

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By Technology

        18.5.4. By Distribution Channel

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

    18.9. Country Level Analysis & Forecast

        18.9.1. China Insulin Delivery Pens Market Analysis

            18.9.1.1. Introduction

            18.9.1.2. Market Analysis and Forecast by Market Taxonomy

                18.9.1.2.1. By Product

                18.9.1.2.2. By Technology

                18.9.1.2.3. By Distribution Channel

        18.9.2. Japan Insulin Delivery Pens Market Analysis

            18.9.2.1. Introduction

            18.9.2.2. Market Analysis and Forecast by Market Taxonomy

                18.9.2.2.1. By Product

                18.9.2.2.2. By Technology

                18.9.2.2.3. By Distribution Channel

        18.9.3. South Korea Insulin Delivery Pens Market Analysis

            18.9.3.1. Introduction

            18.9.3.2. Market Analysis and Forecast by Market Taxonomy

                18.9.3.2.1. By Product

                18.9.3.2.2. By Technology

                18.9.3.2.3. By Distribution Channel

19. Oceania Insulin Delivery Pens Market 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By Technology

        19.4.4. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Technology

        19.5.4. By Distribution Channel

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia Insulin Delivery Pens Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Technology

                19.8.1.2.3. By Distribution Channel

        19.8.2. New Zealand Insulin Delivery Pens Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Technology

                19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Insulin Delivery Pens Market Analysis 2014-2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2014-2021

    20.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Turkey

            20.4.1.3. South Africa

            20.4.1.4. North Africa

            20.4.1.5. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By Technology

        20.4.4. By Distribution Channel

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By Technology

        20.5.4. By Distribution Channel

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

    20.9. Country Level Analysis & Forecast

        20.9.1. GCC Countries Insulin Delivery Pens Market Analysis

            20.9.1.1. Introduction

            20.9.1.2. Market Analysis and Forecast by Market Taxonomy

                20.9.1.2.1. By Product

                20.9.1.2.2. By Technology

                20.9.1.2.3. By Distribution Channel

        20.9.2. Turkey Insulin Delivery Pens Market Analysis

            20.9.2.1. Introduction

            20.9.2.2. Market Analysis and Forecast by Market Taxonomy

                20.9.2.2.1. By Product

                20.9.2.2.2. By Technology

                20.9.2.2.3. By Distribution Channel

        20.9.3. South Africa Insulin Delivery Pens Market Analysis

            20.9.3.1. Introduction

            20.9.3.2. Market Analysis and Forecast by Market Taxonomy

                20.9.3.2.1. By Product

                20.9.3.2.2. By Technology

                20.9.3.2.3. By Distribution Channel

        20.9.4. North Africa Insulin Delivery Pens Market Analysis

            20.9.4.1. Introduction

            20.9.4.2. Market Analysis and Forecast by Market Taxonomy

                20.9.4.2.1. By Product

                20.9.4.2.2. By Technology

                20.9.4.2.3. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Becton, Dickinson and Company

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Sales Footprint

            22.3.1.4. SWOT Analysis

            22.3.1.5. Key Financials

            22.3.1.6. Strategy Overview

        22.3.2. Eli Lilly and Company

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Sales Footprint

            22.3.2.4. SWOT Analysis

            22.3.2.5. Key Financials

            22.3.2.6. Strategy Overview

        22.3.3. West Pharmaceutical Services, Inc

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Sales Footprint

            22.3.3.4. SWOT Analysis

            22.3.3.5. Key Financials

            22.3.3.6. Strategy Overview

        22.3.4. Johnson & Johnson

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Sales Footprint

            22.3.4.4. SWOT Analysis

            22.3.4.5. Key Financials

            22.3.4.6. Strategy Overview

        22.3.5. Antares Pharma

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Sales Footprint

            22.3.5.4. SWOT Analysis

            22.3.5.5. Key Financials

            22.3.5.6. Strategy Overview

        22.3.6. AbbVie Inc.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Sales Footprint

            22.3.6.4. SWOT Analysis

            22.3.6.5. Key Financials

            22.3.6.6. Strategy Overview

        22.3.7. Pfizer Inc

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Sales Footprint

            22.3.7.4. SWOT Analysis

            22.3.7.5. Key Financials

            22.3.7.6. Strategy Overview

        22.3.8. Mylan N.V

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Sales Footprint

            22.3.8.4. SWOT Analysis

            22.3.8.5. Key Financials

            22.3.8.6. Strategy Overview

        22.3.9. Vetter Pharma-Fertigung GmbH & Co.KG

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Sales Footprint

            22.3.9.4. SWOT Analysis

            22.3.9.5. Key Financials

            22.3.9.6. Strategy Overview

        22.3.10. Emperra GmbH

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Sales Footprint

            22.3.10.4. SWOT Analysis

            22.3.10.5. Key Financials

            22.3.10.6. Strategy Overview

        22.3.11. Digital Medics Pty Ltd

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. Sales Footprint

            22.3.11.4. SWOT Analysis

            22.3.11.5. Key Financials

            22.3.11.6. Strategy Overview

        22.3.12. Enable Injections LLC

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. Sales Footprint

            22.3.12.4. SWOT Analysis

            22.3.12.5. Key Financials

            22.3.12.6. Strategy Overview

        22.3.13. Insulet corporation

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. Sales Footprint

            22.3.13.4. SWOT Analysis

            22.3.13.5. Key Financials

            22.3.13.6. Strategy Overview

        22.3.14. Consort Medical Plc

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. Sales Footprint

            22.3.14.4. SWOT Analysis

            22.3.14.5. Key Financials

            22.3.14.6. Strategy Overview

        22.3.15. Diabnext

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. Sales Footprint

            22.3.15.4. SWOT Analysis

            22.3.15.5. Key Financials

            22.3.15.6. Strategy Overview

        22.3.16. Diamesco Co., Ltd

            22.3.16.1. Overview

            22.3.16.2. Product Portfolio

            22.3.16.3. Sales Footprint

            22.3.16.4. SWOT Analysis

            22.3.16.5. Key Financials

            22.3.16.6. Strategy Overview

        22.3.17. SCHOTT AG

            22.3.17.1. Overview

            22.3.17.2. Product Portfolio

            22.3.17.3. Sales Footprint

            22.3.17.4. SWOT Analysis

            22.3.17.5. Key Financials

            22.3.17.6. Strategy Overview

        22.3.18. SiO2 Medical Products

            22.3.18.1. Overview

            22.3.18.2. Product Portfolio

            22.3.18.3. Sales Footprint

            22.3.18.4. SWOT Analysis

            22.3.18.5. Key Financials

            22.3.18.6. Strategy Overview

        22.3.19. Integrity Bio, Inc.

            22.3.19.1. Overview

            22.3.19.2. Product Portfolio

            22.3.19.3. Sales Footprint

            22.3.19.4. SWOT Analysis

            22.3.19.5. Key Financials

            22.3.19.6. Strategy Overview

        22.3.20. Wilhelm Haselmeier GmbH & Co. KG

            22.3.20.1. Overview

            22.3.20.2. Product Portfolio

            22.3.20.3. Sales Footprint

            22.3.20.4. SWOT Analysis

            22.3.20.5. Key Financials

            22.3.20.6. Strategy Overview

        22.3.21. Tandem Diabetes Care

            22.3.21.1. Overview

            22.3.21.2. Product Portfolio

            22.3.21.3. Sales Footprint

            22.3.21.4. SWOT Analysis

            22.3.21.5. Key Financials

            22.3.21.6. Strategy Overview

        22.3.22. Sanofi S.A.

            22.3.22.1. Overview

            22.3.22.2. Product Portfolio

            22.3.22.3. Sales Footprint

            22.3.22.4. SWOT Analysis

            22.3.22.5. Key Financials

            22.3.22.6. Strategy Overview

        22.3.23. Companion Medical Inc.

            22.3.23.1. Overview

            22.3.23.2. Product Portfolio

            22.3.23.3. Sales Footprint

            22.3.23.4. SWOT Analysis

            22.3.23.5. Key Financials

            22.3.23.6. Strategy Overview

        22.3.24. Ypsomed

            22.3.24.1. Overview

            22.3.24.2. Product Portfolio

            22.3.24.3. Sales Footprint

            22.3.24.4. SWOT Analysis

            22.3.24.5. Key Financials

            22.3.24.6. Strategy Overview

        22.3.25. Hoffman - La Roche Ltd

            22.3.25.1. Overview

            22.3.25.2. Product Portfolio

            22.3.25.3. Sales Footprint

            22.3.25.4. SWOT Analysis

            22.3.25.5. Key Financials

            22.3.25.6. Strategy Overview

        22.3.26. Novo Nordisk A/S

            22.3.26.1. Overview

            22.3.26.2. Product Portfolio

            22.3.26.3. Sales Footprint

            22.3.26.4. SWOT Analysis

            22.3.26.5. Key Financials

            22.3.26.6. Strategy Overview

        22.3.27. Medtronic Plc.

            22.3.27.1. Overview

            22.3.27.2. Product Portfolio

            22.3.27.3. Sales Footprint

            22.3.27.4. SWOT Analysis

            22.3.27.5. Key Financials

            22.3.27.6. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 02: Global Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 03: Global Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 04: Global Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 05: Global Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Region

Table 06: North America Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 07: North America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 08: North America Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 09: North America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 10: North America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 11: Latin America Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 12: Latin America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 13: Latin America Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 14: Latin America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 15: Latin America Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 16: Europe Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 17: Europe Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 18: Europe Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 19: Europe Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 20: Europe Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 21: South Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 22: South Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 23: South Asia Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 24: South Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 25: South Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 26: East Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 27: East Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 28: East Asia Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 29: East Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 30: East Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 31: Oceania Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 32: Oceania Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 33: Oceania Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 34: Oceania Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 35: Oceania Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Table 36: MEA Insulin Delivery Pens Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2032, by Country

Table 37: MEA Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 38: MEA Insulin Delivery Pens Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 39: MEA Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Technology

Table 40: MEA Insulin Delivery Pens Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Insulin Delivery Pens Market Volume (Units), 2014– 2021

Figure 02: Global Insulin Delivery Pens Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: XYZ, Pricing Analysis per unit (US$), in 2022

Figure 04: XYZ, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 06: Global Insulin Delivery Pens Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Insulin Delivery Pens Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 08: Global Insulin Delivery Pens Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Insulin Delivery Pens Market Y-o-Y Growth (%) Analysis 2021-2032, by Product

Figure 10: Global Insulin Delivery Pens Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Insulin Delivery Pens Market Value Share (%) Analysis 2022 and 2032, by Technology

Figure 12: Global Insulin Delivery Pens Market Y-o-Y Growth (%) Analysis 2021-2032, by Technology

Figure 13: Global Insulin Delivery Pens Market Attractiveness Analysis 2022–2032, by Technology

Figure 14: Global Insulin Delivery Pens Market Value Share (%) Analysis 2022 and 2032, by Distribution Channel

Figure 15: Global Insulin Delivery Pens Market Y-o-Y Growth (%) Analysis 2021-2032, by Distribution Channel

Figure 16: Global Insulin Delivery Pens Market Attractiveness Analysis 2022–2032, by Distribution Channel

Figure 17: Global Insulin Delivery Pens Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 18: Global Insulin Delivery Pens Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 19: Global Insulin Delivery Pens Market Attractiveness Analysis 2022–2032, by Region

Figure 20: North America Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 21: North America Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 22: North America Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 23: North America Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 24: North America Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 25: North America Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 26: North America Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 27: North America Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 28: North America Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 29: North America Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 30: U.S. Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 31: Global Vs. U.S. Growth Comparison, 2021 - 2032

Figure 32: U.S. Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 33: U.S. Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 34: U.S. Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 35: Canada Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 36: Global Vs. Canada. Growth Comparison, 2021 - 2032

Figure 37: Canada Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 38: Canada Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 39: Canada Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 40: Latin America Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 41: Latin America Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 42: Latin America Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 43: Latin America Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 44: Latin America Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 45: Latin America Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 46: Latin America Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 47: Latin America Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 48: Latin America Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 49: Latin America Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 50: Mexico Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 51: Global Vs Mexico Growth Comparison, 2021 - 2032

Figure 52: Mexico Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 53: Mexico Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 54: Mexico Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 55: Brazil Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 56: Global Vs. Brazil. Growth Comparison, 2021 - 2032

Figure 57: Brazil Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 58: Brazil Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 59: Brazil Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 60: Argentina Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 61: Global Vs Argentina Growth Comparison, 2021 - 2032

Figure 62: Argentina Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 63: Argentina Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 64: Argentina Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 65: Europe Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 66: Europe Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 67: Europe Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 68: Europe Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 69: Europe Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 70: Europe Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 71: Europe Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 72: Europe Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 73: Europe Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 74: Europe Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 75: UK Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 76: Global Vs. UK Growth Comparison, 2021 - 2032

Figure 77: UK Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 78: UK Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 79: UK Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 80: Germany Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 81: Global Vs. Germany Growth Comparison, 2021 - 2032

Figure 82: Germany Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 83: Germany Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 84: Germany Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 85: Italy Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 86: Global Vs. Italy Growth Comparison, 2021 - 2032

Figure 87: Italy Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 88: Italy Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 89: Italy Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 90: France Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 91: Global Vs France Growth Comparison, 2021 - 2032

Figure 92: France Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 93: France Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 94: France Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 95: Spain Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 96: Global Vs Spain Growth Comparison, 2021 - 2032

Figure 97: Spain Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 98: Spain Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 99: Spain Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 100: Russia Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 101: Global Vs Russia Growth Comparison, 2021 - 2032

Figure 102: Russia Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 103: Russia Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 104: Russia Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 105: BENELUX Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 106: Global Vs BENELUX Growth Comparison, 2021 - 2032

Figure 107: BENELUX Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 108: BENELUX Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 109: BENELUX Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 110: East Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 111: East Asia Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 112: East Asia Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 113: East Asia Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 114: East Asia Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 115: East Asia Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 116: East Asia Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 117: East Asia Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 118: East Asia Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 119: East Asia Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 120: China Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 121: Global Vs. China Growth Comparison, 2021 - 2032

Figure 122: China Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 123: China Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 124: China Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 125: Japan Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 126: Global Vs. Japan Growth Comparison, 2021 - 2032

Figure 127: Japan Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 128: Japan Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 129: Japan Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 130: South Korea Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 131: Global Vs South Korea Growth Comparison, 2021 - 2032

Figure 132: South Korea Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 133: South Korea Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 134: South Korea Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 135: South Asia Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 136: South Asia Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 137: South Asia Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 138: South Asia Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 139: South Asia Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 140: South Asia Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 141: South Asia Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 142: South Asia Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 143: South Asia Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 144: South Asia Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 145: India Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 146: Global Vs. India Growth Comparison, 2021 - 2032

Figure 147: India Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 148: India Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 149: India Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 150: Indonesia Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 151: Global Vs. Indonesia Growth Comparison, 2021 - 2032

Figure 152: Indonesia Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 153: Indonesia Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 154: Indonesia Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 155: Malaysia Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 156: Global Vs. Malaysia Growth Comparison, 2021 - 2032

Figure 157: Malaysia Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 158: Malaysia Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 159: Malaysia Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 160: Thailand Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 161: Global Vs. Thailand Growth Comparison, 2021 - 2032

Figure 162: Thailand Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 163: Thailand Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 164: Thailand Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 165: Oceania Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 166: Oceania Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 167: Oceania Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 168: Oceania Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 169: Oceania Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 170: Oceania Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 171: Oceania Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 172: Oceania Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 173: Oceania Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 174: Oceania Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 175: Australia Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 176: Global Vs. Australia Growth Comparison, 2021 - 2032

Figure 177: Australia Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 178: Australia Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 179: Australia Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 180: New Zealand Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 181: Global Vs New Zealand Growth Comparison, 2021 - 2032

Figure 182: New Zealand Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 183: New Zealand Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 184: New Zealand Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 185: Middle East & Africa Insulin Delivery Pens Market Value (US$ Mn) Analysis, 2014–2021

Figure 186: Middle East & Africa Insulin Delivery Pens Market Value (US$ Mn) Forecast, 2022-2032

Figure 187: Middle East & Africa Insulin Delivery Pens Market Value Share, by Product (2022 E)

Figure 188: Middle East & Africa Insulin Delivery Pens Market Value Share, by Technology (2022 E)

Figure 189: Middle East & Africa Insulin Delivery Pens Market Value Share, by Distribution Channel (2022 E)

Figure 190: Middle East & Africa Insulin Delivery Pens Market Value Share, by Country (2022 E)

Figure 191: Middle East & Africa Insulin Delivery Pens Market Attractiveness Analysis by Product, 2022–2032

Figure 192: Middle East & Africa Insulin Delivery Pens Market Attractiveness Analysis by Technology, 2022–2032

Figure 193: Middle East & Africa Insulin Delivery Pens Market Attractiveness Analysis by Distribution Channel, 2022–2032

Figure 194: Middle East & Africa Insulin Delivery Pens Market Attractiveness Analysis by Country, 2022–2032

Figure 195: GCC Countries Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 196: Global Vs GCC Countries Growth Comparison, 2021 - 2032

Figure 197: GCC Countries Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 198: GCC Countries Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 199: GCC Countries Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 200: Turkey Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 201: Global Vs. Turkey Growth Comparison, 2021 - 2032

Figure 202: Turkey Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 203: Turkey Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 204: Turkey Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 205: South Africa Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 206: Global Vs. South Africa Growth Comparison, 2021 - 2032

Figure 207: South Africa Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 208: South Africa Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 209: South Africa Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Figure 210: North Africa Insulin Delivery Pens Market Value Proportion Analysis, 2021

Figure 211: Global Vs North Africa Growth Comparison, 2021 - 2032

Figure 212: North Africa Insulin Delivery Pens Market Share Analysis (%) by Product, 2021 & 2032

Figure 213: North Africa Insulin Delivery Pens Market Share Analysis (%) by Technology, 2021 & 2032

Figure 214: North Africa Insulin Delivery Pens Market Share Analysis (%) by Distribution Channel, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Epinephrine Auto-Injectors Market

Published : June 2022

Healthcare

Insulin Pens Market

Published : July 2021

Healthcare

Diabetes Care Devices Market

Published : January 1970

Google translate

Insulin Delivery Pens Market